Evidence map›Paper›PMID 42686957›Full record

ArticleNature human behaviour2026

Turning biometrics into a commodity raises privacy and governance risks.

Ángel Judel, José M Muñoz, Carlos Amunátegui Perelló, Diego Borbón, José Antonio Iglesias, José Ángel Marinaro, Natalia Monti, Moisés Sánchez, Ciro Colombara, Amanda de la Fuente and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature human behaviour, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ángel JudelCentre for Neurotechnology and Law (CNL), London, UK.ORCID http://orcid.org/0009-0006-2626-4102
José M MuñozCentre for Neurotechnology and Law (CNL), London, UK. jmmunoz@inecenter.com.ORCID http://orcid.org/0000-0002-1456-9439
Carlos Amunátegui PerellóCentre for Neurotechnology and Law (CNL), London, UK.
Diego BorbónUniversidad Externado de Colombia, Bogotá, Colombia.
José Antonio IglesiasUniversidad de la República, Montevideo, Uruguay.
José Ángel MarinaroCentre for Neurotechnology and Law (CNL), London, UK.
Natalia MontiFundación Kamanau, Buenos Aires, Argentina.
Moisés SánchezFundación Kamanau, Santiago, Chile.
Ciro ColombaraFundación Kamanau, Santiago, Chile.
Amanda de la FuenteColombara Estrategia Legal, Santiago, Chile.
Aldo DíazColombara Estrategia Legal, Santiago, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42686957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.